Skip to main content
OpenTrials

Clinical trial condition

Thrombotic Microangiopathies

Explore clinical trials studying Thrombotic Microangiopathies. Study availability and eligibility vary by location and protocol.

404 public trials 103 recruiting studies
Refine in advanced search Browse all conditions

Thrombotic Microangiopathies trial results

Active, not recruiting

A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids

NCT05653219

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Yuma Regional Medical Center Yuma, Arizona, United States
  • University of Colorado Anschutz Aurora, Colorado, United States
  • NorthShore University Health System Evanston, Illinois, United States
  • Boston Medical Center Boston, Massachusetts, United States
View all 74 locations
View Trial Details
Active, not recruiting

A Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns and Outcomes in Atypical Hemolytic Uremic Syndrome Patients

NCT06099236

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +15 more
Locations
  • Research Site Beijing, Beijing Municipality, China
  • Research Site Chongqing, Sichuan, China
  • Research Site Anhui, China
  • Research Site Beijing, China
View all 26 locations
View Trial Details
Active, not recruiting

A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

NCT04861259

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
Locations
  • Univ of CA San Francisco San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Emory Children's Center Atlanta, Georgia, United States
  • Washington University St Louis, Missouri, United States
View all 42 locations
View Trial Details
Active, not recruiting

Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)

NCT05653349

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Yuma Regional Medical Center Yuma, Arizona, United States
  • Community Cancer Institute Clovis, California, United States
  • Compassionate Care Res Group Inc Fountain Valley, California, United States
  • University of Colorado Anschutz Aurora, Colorado, United States
View all 111 locations
View Trial Details
Active, not recruiting

A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

NCT04683003

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +14 more
Locations
  • Childrens Healthcare of Atlanta Atlanta, Georgia, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Mid Ohio Heart Clinic Inc Dublin, Ohio, United States
View all 27 locations
View Trial Details
Active, not recruiting

Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)

NCT04562766

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • University of Southern California_Investigational Site Number 84024 Los Angeles, California, United States
  • UCSF Benioff Children's Hospital San Francisco_Investigational Site Number 84020 San Francisco, California, United States
  • Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center_Investigational Site Number 84037 Torrance, California, United States
  • The Oncology Institute of Hope and Innovation_Investigational Site Number 84031 Whittier, California, United States
View all 155 locations
View Trial Details

Related conditions